Vaccination Against RhoC in Prostate Cancer Patients Induces Potent and Long-Lasting CD4+ T Cell Responses with Cytolytic Potential in the Absence of Clinical Efficacy: A Randomized Phase II Trial

DSpace Repository

Vaccination Against RhoC in Prostate Cancer Patients Induces Potent and Long-Lasting CD4+ T Cell Responses with Cytolytic Potential in the Absence of Clinical Efficacy: A Randomized Phase II Trial

Author: Salo, Sara Fresnillo; Schuhmacher, Juliane; Rahbech, Anne; Pedersen, Sara Ram; Seremet, Tina; Matillas, Valero Andreu; Schoellhorn, Anna; Roder, Andreas; Jorgensen, Steffen Wad; Brasso, Klaus; Gouttefangeas, Cecile; Straten, Per thor
Tübinger Autor(en):
Schuhmacher, Juliane
Matillas, Valero Andreu
Schöllhorn, Anna
Gouttefangeas, Cécile
Published in: Vaccines (2025), Bd. 13 (4), Article 390
Verlagsangabe: Basel : Mdpi
Language: English
Full text: http://dx.doi.org/10.3390/vaccines13040390
ISSN: 2076-393X
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)